Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 41

Trial Status

Completed2
Terminated1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT04809207Not ApplicableCompleted
Acceptability, Feasibility and Preliminary Efficacy of CFWP to Treat Clinically Elevated Fatigue in Adults With CF
Cystic FibrosisFatigue
PrincipalinvestigatorStart date: 2021-05-01
NCT01349192Phase 2Terminated
Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)
Cystic FibrosisMethicillin-resistant Staphylococcus Aureus
PrincipalinvestigatorStart date: 2011-04-01
NCT02781610Phase 4Completed
Standardized Treatment of Pulmonary Exacerbations II
Pulmonary Cystic Fibrosis
Principalinvestigator

Research Network

Collaboration Network

7 collaborators·6 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Patrick Flume, MD

Medical University of South Carolina

Moderately Similar
4 trials

Shared therapeutic areas:

Cystic FibrosisMethicillin-Resistant Staphylococcus aureusPulmonary Cystic Fibrosis

Worked with same sponsors:

CF Therapeutics Development Network Coordinating CenterChris Goss+3 more
Collaborated on 1 trial
Similarity Score34%

Kristin Riekert, PhD

Johns Hopkins University

Related
4 trials

Shared therapeutic areas:

Cystic FibrosisFatigue

Worked with same sponsors:

Cystic Fibrosis FoundationJohns Hopkins University+2 more
Collaborated on 1 trial
Similarity Score24%

Marianne S Muhlebach, MD

UNC Children's Hospital

Related
1 trials

Shared therapeutic areas:

Cystic FibrosisMethicillin-Resistant Staphylococcus aureus

Worked with same sponsors:

Baylor College of MedicineCF Therapeutics Development Network Coordinating Center+12 more
Collaborated on 1 trial
Similarity Score24%

Jae-Joon Yim, MD

Seoul National University Hospital

Related
10 trials

Shared therapeutic areas:

Methicillin-Resistant Staphylococcus aureus
Similarity Score8%

Shawn Aaron, MD

The Ottawa Hospital

Related
2 trials

Shared therapeutic areas:

Cystic Fibrosis
Similarity Score8%

Marco A Vaz, PhD

Federal University of Rio Grande do Sul

Related
10 trials

Shared therapeutic areas:

Fatigue
Similarity Score8%

Rémi Rabasa-Lhoret

Institut de Recherches Cliniques de Montreal

Related
16 trials

Shared therapeutic areas:

Cystic Fibrosis
Similarity Score8%

Davide CAIMMI

University Hospital, Montpellier

Related
10 trials

Shared therapeutic areas:

Cystic Fibrosis
Similarity Score8%

Averell Sherker, MD

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Related
11 trials

Shared therapeutic areas:

Cystic Fibrosis

Worked with same sponsors:

Cystic Fibrosis Foundation
Similarity Score8%

Charles L. Loprinzi, MD

Mayo Clinic

Related
14 trials

Shared therapeutic areas:

Fatigue
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT04809207Not ApplicablePrincipalInvestigator

Acceptability, Feasibility and Preliminary Efficacy of CFWP to Treat Clinically Elevated Fatigue in Adults With CF

Cystic FibrosisFatigue
Completed
NCT01349192Phase 2PrincipalInvestigator

Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)

Cystic FibrosisMethicillin-resistant Staphylococcus Aureus
Terminated
NCT02781610Phase 4PrincipalInvestigator

Standardized Treatment of Pulmonary Exacerbations II

Pulmonary Cystic Fibrosis
Completed

All 3 trials loaded